1Mailliar RB, Dallal RM, Son Yi, et al. Dendritic cells promote Tcells survivul or death depending upon their maturation state and presentation of antigen. Immunol Invest,2000,29:177-185. 被引量:1
2Jeffes EW 3rd, Lee GC, Said S, et al . Elevated numbers of proliferating mononuclear cells in the peripheral blood of psoriatic patients correlate with disease severity. J Invest Dermatol, 1995,105:733-738. 被引量:1
3Yu Y, Tang L, Wang J, et al. Psoriatic lesional keratinocytes promote the maturation of human monocyte-derived Langer hans cells. Dermatology, 2002,204:94-99. 被引量:1
4Hodak E,Gottlieb AB,Segal T, et al. Climatotherapy at the Dead Sea is a rem ittive therapy for psoriasis: combined effects on epidermal and immunologic activation. J Am Acad Dermatol, 2003,49: 451-457. 被引量:1
5Chamian F, Lowes MA,Lin SL,et al. Alefacept reduces infiltrating T cells, activated dendritic cells, and inflammatory genes in psoriasis vulgaris. Proc Natl Acad Sci USA, 2005,102:2075-2080. 被引量:1
6Abrams JR, Kelley SL, Hayes E, et al. Blockade ofT lymphocyte costimulation with cytotoxic T lymphocyte-associated antigen 4-immunoglobulin (CTLA4Ig) reverses the cellular pathology of psoriatic plaques, including the activation of keratinocytes, dendritic cells, and endothelial cells. J Exp Med, 2000,4:681-694. 被引量:1
7Koga T, Duan H, Urabe K, et al. In situlocalization of CD83-positive dendritic cells in psoriatic lesions. Dermatology,2002,204:100-103. 被引量:1
8Cumberbatch M, Singh M, Dearman R J, et al. Impaired Langerhans cell migretion in psoriasis.J EXP Med,2006,203:953-960. 被引量:1
9Nestle FO, Filgueira L, Nickoloff BJ, et al. Human dermal dendritic cellS process and present soluble protein antigens. J Invest Dermatol, 1998, 110: 762-766. 被引量:1
10Johanson O, Hilliges M, Talme T, et al. Somatostat in immunoreactive cells in psoriatic human skin during peptide T treatment. Acta DermVenereol, 1994,74:106-109. 被引量:1